Prm157 - The Impact of Landmark Response on Overall Survival: Implications for the Economic Evaluation of Immune-Therapy (I-O) Treatment in Small Cell Lung Cancer (Sclc)

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2277

Related search